BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2011
View Archived Issues
TIGEM describes HDAd-based gene therapy for primary hyperoxaluria type 1 / News in Context
Read More
Novel neurotransmitter modulators patented
Read More
Top-line phase I data on VRS-859 for type 2 diabetes
Read More
VBI Vaccines completes acquisition of Epixis
Read More
Zofran may be associated with abnormal heart rhythms
Read More
Dovitinib assessed in HER2- breast cancer stratified by FGFR1 and HR amplification statuses
Read More
Novel treatment strategy for leukemia targets oncogene upregulation
Read More
Phase II trial evaluates FV-100 for pain associated with shingles
Read More
Novel protein kinase inhibitors patented by DCAM Pharma
Read More
Ono Pharmaceutical secures new Japanese approval for Glactiv
Read More
Catabasis Pharmaceuticals identifies new NF-kappa-B activation inhibitors
Read More
Vivus reaches agreement with FDA on Qnexa NDA
Read More
PROLOR Biotech presents promising preclinical data on FVIIa-CTP
Read More
BioLineRx receives European confirmation of regulatory pathway for BL-5010
Read More
New antivirals described by Gilead Sciences
Read More
New curcumin derivatives reported for Alzheimers disease
Read More
Alkermes completes merger with Elan Drug Technologies
Read More
Phosphagenics set to begin pivotal trials of TPM technology-delivered oxycodone patch
Read More
Karo Bio obtains clearance for phase III trial in HeFH
Read More
Spinifex Pharmaceuticals commences phase II study of EMA-401
Read More
Merck KGaA acquires exclusive worldwide rights to experimental MS treatment
Read More
Bioheart to seek FDA clearance for phase I ANGEL study
Read More
SMART-5 trial data reported for bazedoxifene/conjugated estrogens
Read More
Pronova BioPharma initiates first-in-human study of PRC-4016
Read More
Velcade approved in Japan for new indication
Read More
Health Canada issues new approval for Lucentis
Read More